Dear Editor,

Senator Bernie Sanders is focusing attention on weight loss drugs, a vital issue given the challenges of obesity. However, his current strategies, such as appealing to other countries and proposing ineffective importation plans, are unproductive. Instead, he should leverage his position as chair of the Health, Education, Labor, and Pensions (HELP) committee to pass laws ensuring affordable access to these medications within the U.S. health system.

Senator Sanders’ claims that weight loss drugs will bankrupt the U.S. healthcare system lack factual basis. Studies have shown that treating obesity is far cheaper than managing related conditions like cardiovascular disease. The real issue is the lack of insurance coverage, which makes these drugs unaffordable for many Americans.

Federal employee insurance plans cover weight loss treatments, yet Medicare does not. This disparity is unfair, especially when safe and effective weight loss medications are now available. Senator Sanders should work to remove the outdated exclusion of weight loss drugs from Medicare, enabling insurance plans to negotiate discounts and reduce costs significantly.

In competitive markets, insurance companies obtain drug discounts for preferred formulary positions, lowering prices for consumers and insurers. This dynamic has kept medicine costs low, with price growth well below consumer inflation. Senator Sanders could champion reforms to ensure pharmacy benefit managers pass these discounts to consumers and protect community pharmacies from predatory practices.

Instead of advocating for external solutions, like Denmark’s socialized medicine or Canadian drug imports, Senator Sanders should focus on effective domestic reforms. Denmark’s system restricts access to many approved medicines, whereas Medicare Part D provides nearly 100% of FDA-approved drugs, giving individuals the power to choose their coverage.

I urge Senator Bill Cassidy to oppose Senator Sanders’ current approach and support practical reforms that expand access to weight loss drugs within the existing competitive market framework. By removing the Medicare exclusion and enabling competition, we can lower prices and help more Americans achieve their weight loss and health goals.

Sincerely,

Lu Jones, RN